Literature DB >> 16626840

Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX.

Vincenzo Calderone1, Francesca Lidia Fiamingo, Irene Giorgi, Michele Leonardi, Oreste Livi, Alma Martelli, Enrica Martinotti.   

Abstract

On the basis of our previous works, addressed to synthesise new activators of BK potassium channels, and of many suggestions from the international literature, a simple pharmacophoric model, consisting of two suitably substituted phenyl rings bound to various kinds of linkers, was hypothesised. In particular, the effectiveness of the amidic linker was demonstrated, since several benzanilide derivatives showed interesting BK-opener properties. As a development of these benzanilides, in this work we introduced heterocyclic substituents, replacing the aryl ring on the acid side or on the basic one of the amide linker of the above pharmacophore. The pharmacological results indicated some relevant remarks about the structural requirements, needed for a satisfactory BK-opener activity. In particular, the presence of a phenolic function, with a possible H-bond donor role, has been confirmed. Furthermore, the presence of nitrogen heterocycles on the acid side of the amide linker seems to be a negative requirement, while furan and thiophene were well tolerated. On the contrary, the introduction of insaturated heterocyclic rings (pyridine and thiazole) on the basic side of the amide linker, led to satisfactory biological activity, while the presence of aliphatic heterocycles lowered the pharmacological effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16626840     DOI: 10.1016/j.ejmech.2006.03.009

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

1.  N-Butyl-4-chloro-benzamide.

Authors:  Aamer Saeed; Rasheed Ahmad Khera; Naeem Abbas; Jim Simpson; Roderick G Stanley
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-13

2.  N-Cyclo-hexyl-3,4,5-trimethoxy-benzamide.

Authors:  Aamer Saeed; Muhammad Arshad; Rasheed Ahmad Khera; Michael Bolte
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-28

3.  N-(4-Methoxy-phen-yl)pivalamide.

Authors:  Aamer Saeed; Shahid Hussain; Mahira Batool; Ulrich Flörke
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-08-08

4.  4-Chloro-N-m-tolyl-benzamide.

Authors:  Aamer Saeed; Madiha Irfan; Michael Bolte
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-05-20

5.  4-Chloro-N-cyclo-hexyl-benzamide.

Authors:  Aamer Saeed; Rasheed Ahmad Khera; Muhammad Latif; Masood Parvez
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-06-10

6.  N-(4-Nitro-phen-yl)cinnamamide.

Authors:  Aamer Saeed; Rasheed Ahmad Khera; Muhammad Shahid; Masood Parvez
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-08-08

7.  2-Methyl-N-p-tolyl-benzamide: a second monoclinic polymorph.

Authors:  Aamer Saeed; Rasheed Ahmad Khera; Jim Simpson
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-03-24

8.  Crystal structure of N-(2-hy-droxy-5-methyl-phen-yl)benzamide.

Authors:  Rodolfo Moreno-Fuquen; Nory J Mariño; Alan R Kennedy
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-11-14

9.  Vascular Effects of the Polyphenolic Nutraceutical Supplement Taurisolo®: Focus on the Protection of the Endothelial Function.

Authors:  Alma Martelli; Lorenzo Flori; Era Gorica; Eugenia Piragine; Anella Saviano; Giuseppe Annunziata; Matteo Nicola Dario Di Minno; Roberto Ciampaglia; Ilenia Calcaterra; Francesco Maione; Gian Carlo Tenore; Ettore Novellino; Vincenzo Calderone
Journal:  Nutrients       Date:  2021-05-02       Impact factor: 5.717

10.  Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides.

Authors:  Malgorzata Kucinska; Maria-Dolores Giron; Hanna Piotrowska; Natalia Lisiak; Walter H Granig; Francisco-Javier Lopez-Jaramillo; Rafael Salto; Marek Murias; Thomas Erker
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.